Abstract
INTRODUCTION:Guillain-Barre syndrome (GBS) has recently been associated with SARS-CoV-2 infection and vaccination. The objective of this review is to describe the sociodemographic data and the clinical presentation of GBS associated with infection and vaccination against COVID-19.
MATERIALS AND METHODS:A systematic search was performed in the Medline, Embase and LILACS databases. Case reports published in 2021-2022 are included. From the selected articles, age, sex, comorbidi-ties, vaccine brand, symptom onset time, clinical manifestations, diagnostic method, treatment received and outcome were extracted.
RESULTS:93 articles were selected, reporting a total of 131 cases: 82 associated with SARS-CoV-2 infection and 49 associated with vaccination against COVID-19. The most affected population was the male sex and was between 31 and 65 years old. The main manifestations described were: limb paresis, compromised sensitivity, areflexia, compromised cranial nerves.
DISCUSSION:The clinical picture of GBS presented characteristics similar to the classic presentation. Dys-autonomia and respiratory failure are the main fatal complications of this entity.
CONCLUSION:GBS can present in a postinfectious, parainfectious manner. It should be suspected when consulting for a clinical picture of demyelinating neuropathy with a history of immunization or concomitant symptoms suggestive of COVID-19. More studies are needed to establish an association between the virus and GBS.
References
Esteban Molina A, Mata Martínez M, Sánchez Chueca P, Carrillo López A, Sancho Val I, Sanjuan-Villarreal TA. Guillain- Barré syndrome associated with SARS-CoV-2 infection. Med Intensiva (Engl Ed). 2020;44(8):513-4. doi: 10.1016/j.medin.2020.04.015.
Wijdicks EF, Klein CJ. Guillain-Barré syndrome. Mayo Clin Proc. 2017;92(3): 467-79. doi: 10.1016/j.mayocp.2016.12.002.
González G, Giraldo G, González A, Ramírez C. Síndrome Guillain-Barré: una mirada actual. RFS. 2016;8(2):38-45. doi: https://doi.org/10.25054/rfs.v8i2.1408.
Parra B, Lizarazo J, Jiménez-Arango J, Zea-Vera A, González- Manrique G, Vargas J, et al. Guillain-Barré syndrome associated with zika virus infection in Colombia. N Engl J Med. 2016;375:1513-23 doi: 10.1056/NEJMoa1605564.
Phillips Morales Ó. Actualización en el síndrome de Guillain- Barré. Rev Méd Sinerg. 2019;4(11):e290. doi: https://doi.org/10.31434/rms.v4i11.290.
Cepeda-Bareño DF, Delgado-Serrano J. Síndrome de Guillain- Barré posterior a vacunación en lactante menor. Rev CES Med. 2020;34(2):162-8. doi: 10.21615/cesmedicina.34.2.8.
Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barré syndrome spectrum associated with COVID- 19: an up-to-date systematic review of 73 cases. J Neurol. 2021;268(4):1133-70. doi: 10.1007/s00415-020-10124-x.
Bohórquez Rivero JJ, Sáenz López JD, Tatis Villamizar KE, Guzmán Sáenz RC. Aspectos fisiopatológicos y manifestaciones neurológicas asociadas a la infección por SARSCoV-2/COVID- 19. Rev Cienc Biomed. 2021;10(1):39-54. doi: 10.32997/rcb-2021-3235.
Cortés ME. Enfermedad por coronavirus 2019 (COVID-19): importancia de sus potenciales efectos neurológicos. Rev Ecuatoriana de Neurol. 2020;29(1):16-7.
Zuberbühler P, Conti ME, León Cejas L, Maximiliano González F, Bonardo P, Miquelini A, et al. Síndrome de Guillain-Barré asociado a infección por COVID-19: revisión de casos publicados. Rev Neurol. 2021;72:203-12. doi: 10.33588/rn.7206.2020487
García-Marmolejo J, Valencia-Cifuentes V. Aspectos neuropatológicos y manifestaciones clínicas asociadas al covid-19: una revisión de la literatura. SSS 2020;6(1):76-7. https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/2336
Coronavirus (COVID-19) Update: July 13, 2021 [Internet]. U.S. Food and Drug Administration. 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-july-13-2021
Angarita JA, Cardenas MP. Síndrome de Guillain-Barré tras vacunación contra SARS-CoV-2 con Sinovac. Acta Neurol Colomb. 2021;37(2):107-8. doi: 10.22379/24224022365.
Bueso T, Montalvan V, Lee J, Gomez J, Ball S, Shoustari A, et al. Guillain-Barre syndrome and COVID-19: a case report. Clin Neurol Neurosurg. 2021;200:106413. doi: 10.1016/j.clineuro.2020.106413.
Agosti E, Giorgianni A, D’Amore F, Vinacci G, Balbi S, Locatelli D. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review. Neurol Sci. 2021;42(2):607-12. doi: 10.1007/s10072-020-04553-9.
Dufour C, Co TK, Liu A. GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome - A case report, systemic review and implication for vaccine development. Brain Behav Immun Health. 2021;12:100203. doi: 10.1016/j.bbih.2021.100203.
Raahimi MM, Kane A, Moore CE, Alareed AW. Late onset of Guillain-Barré syndrome following SARS-CoV-2 infection: part of “long COVID-19 syndrome”? BMJ Case Rep. 2021;14(1):e240178. doi: 10.1136/bcr-2020-240178.
Defabio AC, Scott TR, Stenberg RT, Simon EL. Guillain-Barré syndrome in a patient previously diagnosed with COVID-19. Am J Emerg Med. 2021;45:154-5. doi: 10.1016/j.ajem.2020.07.074.
Pelea T, Reuter U, Schmidt C, Laubinger R, Siegmund R, Walther BW. SARS-CoV-2 associated Guillain-Barré syndrome. J Neurol. 2021;268(4):1191-4. doi: 10.1007/s00415-020-10133-w.
Singh R, Shiza ST, Saadat R, Dawe M, Rehman U. Association of Guillain-Barre syndrome With COVID-19: a case report and literature review. Cureus. 2021;13(3):e13828. doi: 10.7759/cureus.13828.
Mackenzie N, Lopez-Coronel E, Dau A, Maloof D, Mattar S, Garcia JT, Fontecha B, Lanata CM, Guillen-Burgos HF. Concomitant Guillain-Barre syndrome with COVID-19: a case report. BMC Neurol. 2021;21(1):135. doi: 10.1186/s12883-021-02162-3.
Singhai A, Budhiraja A. Guillain-Barre syndrome following SARS-COVID-19 infection: a case report from India. Case Rep Infect Dis. 2021;2021:4676659. doi: 10.1155/2021/4676659.
Hanif M, Khan AW, Khan MA, Sundas F, Khan SJ. COVID- 19-induced Guillain-Barre syndrome: a rare complication of SARS-CoV-2 infection. J Coll Physicians Surg Pak. 2021;31(7):123-4. doi: 10.29271/jcpsp.2021.Supp2.S123.
Meshref M, Alshammari H, Khairat SM, Khan R, Khan I. Guillain-Barre syndrome associated with COVID-19 infection: a case report with review of literature. Cureus. 2021;13(2):e13096. doi: 10.7759/cureus.13096.
Gagarkin DA, Dombrowski KE, Thakar KB, DePetrillo JC. Acute inflammatory demyelinating polyneuropathy or Guillain- Barré syndrome associated with COVID-19: a case report. J Med Case Rep. 2021;15(1):219. doi: 10.1186/s13256-021-02831-4.
El Aidouni G, Touihar S, Merbouh M, Aabdi M, El Kaouini A, Bouabdallaoui A, et al. Guillain Barre syndrome as a complication of SARS-CoV-2 infection: A case report. Ann Med Surg (Lond). 2021;68:102672. doi: 10.1016/j.amsu.2021.102672.
Mokhashi N, Narla G, Marchionni C. Guillain-Barre syndrome in a patient with asymptomatic coronavirus disease 2019 infection and major depressive disorder. Cureus. 2021;13(3):e14161. doi: 10.7759/cureus.14161.
Papri N, Hayat S, Mohammed A, Afsar MNA, Hasan I, Rahman A, et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case report with long term follow up. J Neuroimmunol. 2021;356:577-590. doi: 10.1016/j.jneuroim.2021.577590.
Brown M, Petrassi A, Bureau BL, Khan N, Jha P. SARS-CoV- 2-associated Guillain-Barre syndrome obscured by diabetes mellitus peripheral neuropathy. Cureus. 2021;13(3):e14209. doi: 10.7759/cureus.14209.
Haidary AM, Noor S, Hamed E, Baryali T, Rahmani S, Ahmad M, et al. Acute motor-sensory axonal polyneuropathy variant of Guillain-Barre syndrome complicating the recovery phase of coronavirus disease 2019 infection: a case report. J Med Case Rep. 2021;15(1):379. doi: 10.1186/s13256-021-02988-y.
Chmiela T, Rzepka M, Krzystanek E, Gorzkowska A. A 50-year-old patient with Guillain-Barré syndrome after COVID-19: a case report. Medicina (Kaunas). 2021;57(8):775. doi: 10.3390/medicina57080775.
Sidhom F, Sandhu H. Guillain-Barre syndrome in a patient with COVID-19 infection. Cureus. 2021;13(8):e17052. doi: 10.7759/cureus.17052.
Kajita M, Sato M, Iizuka Y, Mashimo Y, Furuta N, Kakizaki S. Guillain-Barré syndrome after SARS-CoV-2 infection. J Gen Fam Med. 2021: doi: 10.1002/jgf2.481.
Brooks JE, Mix FM, Buck JC, Walters RA. COVID-19-induced Guillain-Barré syndrome. Cureus. 2021;13(11):e19809. doi: 10.7759/cureus.19809.
Kakumoto T, Kobayashi S, Yuuki H, Kainaga M, Shirota Y, Hamada M, et al. Cranial nerve involvement and dysautonomia in post-COVID-19 Guillain-Barré syndrome. Intern Med. 2021;60(21):3477-80. doi: 10.2169/internalmedicine.7355-21.
Nejad JH, Heiat M, Hosseini MJ, Allahyari F, Lashkari A, Torabi R, et al. Guillain-Barré syndrome associated with COVID-19: a case report study. J Neurovirol. 2021;27(5):802-5. doi: 10.1007/s13365-021-00984-y.
?enš?ák D, Ungermann L, Št?tká?ová I, Ehler E. Guillan-Barré syndrome after first vaccination dose against COVID-19: case report. Acta Medica (Hradec Kralove). 2021;64(3):183-6. doi: 10.14712/18059694.2021.31.
Biassoni E, Assini A, Gandoglia I, Benedetti L, Boni S, Pontali E, et al. The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation. J Neurovirol. 2021;27(4):662-5. doi: 10.1007/s13365-021-00997-7.
Yakoby J, Litvak I, Yu E. Guillain-Barré syndrome after novel coronavirus disease 2019. J Emerg Med. 2021;61(4):e67-70. doi: 10.1016/j.jemermed.2021.03.022.
Kang M, Seok HY. Finger drop-dominant variant of Guillain- Barre syndrome in a patient with COVID-19: a case report. J Korean Med Sci. 2022;37(20):e160. doi: 10.3346/jkms.2022.37.e160.
Miyajan KF, Alyamani NA, Zafer DO, Tawakul AA. Guillain- Barré syndrome in an elderly patient as a complication of COVID-19 infection. Cureus. 2021;13(10):e19154. doi: 10.7759/cureus.19154.
Shrestha S, Kc N, Hirachan N. Guillain Barre syndrome associated with COVID-19 infection: a case report. JNMA J Nepal Med Assoc. 2021;59(240):808-11. doi: 10.31729/jnma.6710.
Randhawa J, Randhawa HS, Toor P. Pharyngeal-cervical-brachial variant of Guillain-Barré syndrome in a patient of COVID-19 infection. Cureus. 2021;13(9):e17945. doi: 10.7759/cureus.17945.
Mehta SK, Sunder A. Getting paralysed after COVID: Guillain- Barre syndrome. J Family Med Prim Care. 2021;10(7):2706-8. doi: 10.4103/jfmpc.jfmpc_2454_20.
Biswas A, Pandey SK, Kumar D, Vardhan H. Post coronavirus disease-2019 vaccination Guillain-Barré syndrome. Indian J Public Health. 2021;65(4):422-4. doi: 10.4103/ijph.ijph_1716_21.
Kaeley N, Kabi A, Pillai A, Shankar T, Ameena S. Post-COVID-19 Guillain-Barré syndrome: a case report with literature review. Cureus. 2022;14(1):e21246. doi: 10.7759/cureus.21246.
Seixas R, Campoamor D, Lopes J, Bernardo T, Nzwalo H, Pascoalinho D. Occurrence of Guillain-Barre syndrome during the initial symptomatic phase of COVID-19 disease: coincidence or consequence? Cureus. 2021;13(11):e19655. doi: 10.7759/cureus.19655.
Taguchi M, Bonner K, Memon AB. Late-onset Guillain-Barré syndrome and right facial nerve palsy after COVID-19 infection. Case Rep Neurol. 2022;14(1):12-8. doi: 10.1159/000521245.
Ramirez N, Ujueta D, Diaz LF, Folleco LE, Rodríguez A, Gaona I, et al. Guillain-Barré syndrome with bilateral facial diplegia secondary to severe acute respiratory syndrome coronavirus-2 infection: a case report. J Med Case Rep. 2021;15(1):558. doi: 10.1186/s13256-021-03120-w.
Toy E, Kart K. Intensive care management in Guillain Barré syndrome accompanying prolonged COVID-19-A case report. Niger J Clin Pract. 2022;25(2):200-2. doi: 10.4103/njcp.njcp_85_21.
Nigatu D, Tigabu T, Awraris M, Yohannes A, Kebede D. Guillain- Barré syndrome associated with SARS CoV-2 infection: case report. Ethiop J Health Sci. 2022;32(1):205-8. doi: 10.4314/ejhs.v32i1.21.
Aryal R, Karki S, Rajbhandari S, Gajurel BP, Karn R, Rajbhandari R, et al. Guillain-Barré syndrome associated with coronavirus disease 2019: a case from Nepal. Clin Case Rep. 2022;10(3):e05638. doi: 10.1002/ccr3.5638.
Mohammadi SM, Abdi R, Karimi Z, Mortazavi F. Guillain-Barré/ Miller Fisher overlap syndrome in a patient after coronavirus disease-2019 infection: a case report. J Med Case Rep. 2022;16(1):63. doi: 10.1186/s13256-021-03245-y.
ŽIvkovi? V, Ga?i? EM, Djuki? D, Nikoli? S. Guillain-Barré syndrome as a fatal complication of SARS-CoV-2 infection - An autopsy case. Leg Med (Tokyo). 2022. doi: 10.1016/j.legalmed.2022.102074.
Almeida MP, Machado Vaz I, Winck JC, Marques A. Inpatient rehabilitation of a person with Guillain-Barré syndrome associated with COVID-19 infection: An expert interdisciplinary approach to a case study. Physiother Theory Pract. 2022:1-11. doi: 10.1080/09593985.2022.2072252.
Faulkner DL, Scott DS, Flint DNJ. Miller-Fisher syndrome associated with SARS-CoV-2: a case report. Microbes Infect. 2022. 24(5):104954. doi: 10.1016/j.micinf.2022.104954.
Fletman EW, Stumpf N, Kalimullah J, Levinson N, Deboo A. Guillain-Barré syndrome associated with COVID-19: an atypical, late-onset presentation. Neurol Sci. 2021;42:4393-5. doi: 10.1007/s10072-021-05336-66
Yang HB, Lee HS. Facial diplegia: a rare subtype of Guillain-Barré syndrome in a patient with minimally symptomatic COVID-19. J Clin Neurol. 2021;17(4):590-2. doi: 10.3988/jcn.2021.17.4.590.
Minalyan A, Chan V, Zhang Q, Thelmo F. COVID-19 and neurological autoimmunity: a case of SARS-COV-2-induced Guillain-Barré syndrome. Chest. 2021;160(4):A975. doi: 10.1016/j.chest.2021.07.908.
Patti R, De Araujo C, Dalsania N, Gonuguntal V, Atuaka C, De Brito B, et al. Post-infectious demyelinating polyneuropathy secondary to COVID-19 infection. Chest. 2021;160(4):A658-9. doi: 10.1016/j.chest.2021.07.626.
Kamel WA, Ibrahim Ismail I, Al-Hashel JY. Guillain-Barre syndrome following COVID-19 infection: first case report from Kuwait and review of the literature. Dubai Med J. 2021:42-6. doi: 10.1159/000513382.
Ocak O. Guillain-Barré syndrome with bilateral peripheral facial nerve paralysis after COVID-19 infection. Turk J Neurol. 2021;27(Supl. 1):40-2. doi: 10.4274/tnd.2021.78095.
Abolmaali M, Heidari M, Zeinali M, Moghaddam P, Ramezani Ghamsari M, Jamshidi Makiani M, et al. Guillain-Barré syndrome as a parainfectious manifestation of SARS-CoV-2 infection: A case series. J Clin Neurosci. 2021;83:119-22. doi: 10.1016/j.jocn.2020.11.013.
Zubair AS, Zubair AS, Desai K, Abulaban A, Roy B. Guillain- Barré syndrome as a complication of COVID-19. Cureus. 2021;13(1):e12695. doi: 10.7759/cureus.12695.
Manganotti P, Bellavita G, D’Acunto L, Tommasini V, Fabris M, Sartori A, et al. Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barré syndrome and polyneuritis cranialis in COVID-19 patients: A case series. J Med Virol. 2021;93(2):766-74. doi: 10.1002/jmv.26289.
Nanda S, Handa R, Prasad A, Anand R, Zutshi D, Dass SK, et al. Covid-19 associated Guillain-Barre syndrome: Contrasting tale of four patients from a tertiary care centre in India. Am J Emerg Med. 2021;39:125-8. doi: 10.1016/j.ajem.2020.09.029.
Khan F, Sharma P, Pandey S, Sharma D, Vijayavarman V, Kumar N, et al. COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too? J Med Virol. 2021;93(10):6045-9. doi: 10.1002/jmv.27159.
Chan M, Han SC, Kelly S, Tamimi M, Giglio B, Lewis A. A Case series of Guillain-Barré syndrome after COVID-19 infection in New York. Neurol Clin Pract. 2021;11(4):e576-8. doi: 10.1212/CPJ.0000000000000880.
Jasso-Rangel M, Vargas Martinez K, Camacho-Frausto L, Galindo Felix A, Roman-Esquivel J, Lara-Ramírez E. Casos clínicos de los síndromes de Guillain-Barre y Miller-Fisher relacionados con al COVID-19. Rev Méd Inst Mex. 2022;60(1):91-5.
Saini PK, Gupta R, Gupta GK. COVID-19 associated Guillain- Barré section syndrome- a case series. J Clin Diagn Res. 2022 doi: 10.7860/jcdr/2022/56035.16281.
Ünlütürk Z, Öncel C, Hayt? B, Erdo?an C. Different Guillain- Barré syndrome variants associated with COVID-19: report of 4 clinical cases. Turk J Neurol. 2022;28:51-4. doi: 10.4274/tnd.2021.86094.
Elzouki AN, Osman MAM, Ahmed MAE, Al-Abdulmalek A, Altermanini M, Al-Ani HA, et al. COVID-19 infection presented as Guillain-Barre syndrome: report of two new cases and review of 116 reported cases and case series. Travel Med Infect Dis. 2021;44:102-169. doi: 10.1016/j.tmaid.2021.102169.
McKean N, Chircop C. Guillain-Barré syndrome after COVID-19 vaccination. BMJ Case Rep. 2021;14(7):e244125. doi: 10.1136/bcr-2021-244125.
Hasan T, Khan M, Khan F, Hamza G. Case of Guillain-Barré syndrome following COVID-19 vaccine. BMJ Case Rep. 2021;14(6):e243629. doi: 10.1136/bcr-2021-243629.
Razok A, Shams A, Almeer A, Zahid M. Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar. Ann Med Surg (Lond). 2021;67:102540. doi: 10.1016/j.amsu.2021.102540.
Patel SU, Khurram R, Lakhani A, Quirk B. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep. 2021;14(4):e242956. doi: 10.1136/bcr-2021-242956.
Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre Syndrome following Pfizer COVID-19 vaccine. Cureus. 2021;13(2):e13426. doi: 10.7759/cureus.13426.
Ogbebor O, Seth H, Min Z, Bhanot N. Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine: A temporal occurrence, not a causal association. IDCases. 2021;24:e01143. doi: 10.1016/j.idcr.2021.e01143.
Matarneh AS, Al-Battah AH, Farooqui K, Ghamoodi M, Alhatou M. COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect. Clin Case Rep. 2021;9(9):e04756. doi: 10.1002/ccr3.4756.
Jain E, Pandav K, Regmi P, Michel G, Altshuler I. Facial diplegia: a rare, atypical variant of Guillain-Barré syndrome and Ad26. COV2.S vaccine. Cureus. 2021;13(7):e16612. doi: 10.7759/cureus.16612.
Introna A, Caputo F, Santoro C, Guerra T, Ucci M, Mezzapesa DM, et al. Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association? Clin Neurol Neurosurg. 2021;208:106887. doi: 10.1016/j.clineuro.2021.106887.
Rao SJ, Khurana S, Murthy G, Dawson ET, Jazebi N, Haas CJ. A case of Guillain-Barre syndrome following Pfizer COVID-19 vaccine. J Community Hosp Intern Med Perspect. 2021;11(5):597- 600. doi: 10.1080/20009666.2021.1954284.
Scendoni R, Petrelli C, Scaloni G, Logullo FO. Electromyoneurography and laboratory findings in a case of Guillain- Barré syndrome after second dose of Pfizer COVID-19 vaccine. Hum Vaccin Immunother. 2021;17(11):4093-6. doi: 10.1080/21645515.2021.1954826.
Rossetti A, Gheihman G, O’Hare M, Kosowsky JM. Guillain- Barré syndrome presenting as facial diplegia after COVID-19 vaccination: a case report. J Emerg Med. 2021;61(6):e141-5. doi: 10.1016/j.jemermed.2021.07.062.
Bouattour N, Hdiji O, Sakka S, Fakhfakh E, Moalla K, Daoud S, et al. Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Neurol Sci. 2022;43(2):755-61. doi: 10.1007/s10072-021-05733-x.
da Silva GF, da Silva CF, Oliveira RENDN, Romancini F, Mendes RM, Locks A, et al. Guillain-Barré syndrome after coronavirus disease 2019 vaccine: A temporal association. Clin Exp Neuroimmunol. 2022;13(2):92-4. doi: 10.1111/cen3.12678.
Aldeeb M, Okar L, Mahmud SS, Adeli GA. Could Guillain-Barré syndrome be triggered by COVID-19 vaccination? Clin Case Rep. 2022;10(1):e05237. doi: 10.1002/ccr3.5237.
Morehouse ZP, Paulus A, Jasti SA, Bing X. A rare variant of Guillain-Barre syndrome following Ad26.COV2.S Vaccination. Cureus. 2021;13(9):e18153. doi: 10.7759/cureus.18153.
Anjum Z, Iyer C, Naz S, Jaiswal V, Nepal G, Laguio-Vila M, et al. Guillain-Barré syndrome after mRNA-1273 (Moderna) COVID- 19 vaccination: A case report. Clin Case Rep. 2022;10(4):e05733. doi: 10.1002/ccr3.5733.
Thant HL, Morgan R, Paese MM, Persaud T, Diaz J, Hurtado L. Guillain-Barré syndrome After Ad26.COV2.S vaccination. Am J Case Rep. 2022;23:e935275. doi: 10.12659/AJCR.935275.
Nagalli S, Shankar Kikkeri N. Sub-acute onset of Guillain-Barré Syndrome post-mRNA-1273 vaccination: a case report. SN Compr Clin Med. 2022;4(1):41. doi: 10.1007/s42399-022-01124-1.
Luitel P, Poudel B, Upadhyay D, Paudel S, Tiwari N, Gajurel BP, et al. Guillain-Barré syndrome following coronavirus disease vaccine: First report from Nepal. SAGE Open Med Case Rep. 2022; doi: 10.1177/2050313X221100876.
Abi?i? A, Adamec I, Habek M. Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurol Sci. 2022 ;43:1495-7. doi: 10.1007/s10072-021-05776-0.
Hughes DL, Brunn JA, Jacobs J, Todd PK, Askari FK, Fontana RJ. Guillain-Barré syndrome after COVID-19 mRNA vaccination in a liver transplantation recipient with favorable treatment response. Liver Transpl. 2022;28(1):134-7. doi: 10.1002/lt.26279.
Yamakawa M, Nakahara K, Nakanishi T, Nomura T, Ueda M. Miller Fisher syndrome following vaccination against SARS-CoV-2. Intern Med. 2022;61(7):1067-9, doi: 10.2169/internalmedicine.8851-21.
Theuriet J, Richard C, Becker J, Pegat A, Bernard E, Vukusic S. Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report. Rev Neurol. 2021;177(10):1305- 7. https://www.sciencedirect.com/science/article/pii/S0035378721005853
Nishiguchi Y, Matsuyama H, Maeda K, Shindo A, Tomimoto H. Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC Neurol. 2021;21(1):452. doi: 10.1186/s12883-021-02489-x.
Badoiu A, Moranne O, Coudray S, Ion IM. Clinical variant of Guillain-Barre syndrome with prominent facial diplegia after AstraZeneca coronavirus disease 2019 vaccine. J Clin Neuromuscul Dis. 2021;23(2):115-6. doi: 10.1097/CND.0000000000000383.
Trimboli M, Zoleo P, Arabia G, Gambardella A. Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine. Neurol Sci. 2021;42(11):4401-2. doi: 10.1007/s10072-021-05523-5.
Kripalani Y, Lakkappan V, Parulekar L, Shaikh A, Singh R, Vyas P. A rare case of Guillain-Barré syndrome following COVID-19 vaccination. Eur J Case Rep Intern Med. 2021;8(9):002707. doi: 10.12890/2021_002797.
James J, Jose J, Gafoor VA, Smita B, Balaram N. Guillain-Barré syndrome following ChAdOx1 nCoV-19 COVID-19 vaccination: a case series. Neurol Clin Neurosci. 2021;9(5):402-5. doi: 10.1111/ncn3.12537.
Chun JY, Park S, Jung J, Kim S-H, Kim T-S, Choi YJ, et al. Guillain-Barré syndrome after vaccination against COVID-19. Lancet Neurol. 2022;21(2):117-9. https://www.sciencedirect.com/science/article/pii/S1474442221004166
Tabatabaee S, Rezania F, Alwedaie SMJ, Malekdar E, Badi Z, Tabatabaei SM, et al. Post COVID-19 vaccination Guillain- Barre syndrome: three cases. Hum Vaccin Immunother. 2022;18(5):2045153. doi: 10.1080/21645515.2022.2045153.
Maramattom BV, Krishnan P, Paul R, Padmanabhan S, Cherukudal Vishnu Nampoothiri S, Syed AA, et al. Guillain-Barré syndrome following ChAdOx1-S/nCoV-19 vaccine. Ann Neurol. 2021;90(2):312-4. doi: 10.1002/ana.26143.
Allen CM, Ramsamy S, Tarr AW, Tighe PJ, Irving WL, Tanasescu R, et al. Guillain-Barré syndrome variant occurring after SARS-CoV-2 Vaccination. Ann Neurol. 2021;90(2):315-8. doi: 10.1002/ana.26144.
Kim JW, Kim YG, Park YC, Choi S, Lee S, Min HJ, Kim MJ. Guillain-Barre syndrome after two COVID-19 vaccinations: two case reports with follow-up electrodiagnostic Study. J Korean Med Sci. 2022;37(7):e58. doi: 10.3346/jkms.2022.37.e58.
Palaiodimou L, Stefanou MI, Katsanos AH, Fragkou PC, Papadopoulou M, Moschovos C, et al. Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. Eur J Neurol. 2021;28(10):3517-3529. doi: 10.1111/ene.14860.
Yuki N, Hartung, HP. Guillain-Barré syndrome. N Engl J Med. 2012;366(24);2294-304. doi: 10.1056/nejmra1114525.
Malek E, Salameh J. Guillain-Barre syndrome. Semin Neurol. 2019;39(05): 589-95. doi: 10.1055/s-0039-1693005.
Sheikh AB, Chourasia PK, Javed N, Chourasia MK, Suriya SS, Upadhyay S, et al. Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review. J Neuroimmunol. 2021;355:577-577. doi: 10.1016/j.jneuroim.2021.577577.
Leonhard SE, Bresani-Salvi CC, Lyra Batista JD, Cunha S, Jacobs BC, Brito Ferreira ML, et al. Guillain-Barré syndrome related to Zika virus infection: A systematic review and meta-analysis of the clinical and electrophysiological phenotype. PLoS Negl Trop Dis. 2020;14(4):e0008264. doi: 10.1371/journal.pntd.0008264.
Centro para el Control y la Prevención de Enfermedades (CDC). El síndrome de Guillain Barré y la vacuna contra la influenza. 2015. https://espanol.cdc.gov/flu/prevent/guillainbarre.htm
Wang F, Wang D, Wang Y, Li C, Zheng Y, Guo Z, et al. Population-based incidence of Guillain-Barré syndrome during mass immunization with viral vaccines: a pooled analysis. Front Immunol. 2022;13:782198. doi: 10.3389/fimmu.2022.782198.
Perez JC. Síndrome de Guillain Barré (SGB). Actualización. Acta Neurol Colomb. 2006;22:2. https://www.acnweb.org/acta/2006_22_2_201.pdf
Gupta S, Verma R, Sethi R, Garg RK, Malhotra HS, Sharma PK, Rizvi I, Uniyal R. Cardiovascular complications and its relationship with functional outcomes in Guillain-Barré syndrome. QJM. 2020;113(2):93-9. doi: 10.1093/qjmed/hcz225.
Centro Nacional de Vacunación y Enfermedades Respiratorias (CDC). Beneficios de vacunarse contra el COVID-19. 2022. https://espanol.cdc.gov/coronavirus/2019-ncov/vaccines/vaccine-benefits.html
Naranjo Y, García JP, Cortés A, Álvarez D. Síndrome de Guillain- Barré como manifestación neurológica autoinmune asociado a COVID-19: una revisión de la literatura. Rev Colomb Reumatol. 2022;29:S48-55. doi: 10.1016/j.rcreu.2021.01.004
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.